Updates
-
-
Specific Lipids in Cerebrospinal Fluid of Progressive MS Patients Rob Neurons of Energy, Study Finds
The cerebrospinal fluid (CSF) of people with progressive multiple sclerosis (MS) contains elevated levels of specific fatty molecules that disrupt the energy “powerhouses” of ... Read more -
Higher Doses of Opicinumab as Add-on Therapy Fail to Lessen MS Disability, Phase 2 Trial Shows
Treating people with relapsing forms of multiple sclerosis (MS) with opicinumab and Avonex (interferon beta-1a) for 72 weeks did not lead to a dose-dependent reduction ... Read more -
Talking to My Parents About My MS Diagnosis
There is nothing worse than being diagnosed with a disorder that you know nothing about. While it was extremely difficult for me to take ... Read more -
Phase 3 Trial of Ibudilast Planned for SPMS Patients with Inactive Disease, MediciNova Says
A Phase 3 trial is planned to confirm the safety and efficacy of oral ibudilast (MN-166) in treating people with secondary progressive multiple sclerosis ... Read more -
Phase 1 Trial of T20K, Plant Protein-derived Therapy for MS, Doses 1st Group of Healthy Men
A first group of healthy volunteers in a Phase 1 trial assessing the safety and tolerability of T20K, Cyxone‘s plant protein-derived candidate for the ... Read more
-
What can changes in grey matter mean for MS? (Sponsored Post)
The brain is made up of two types of tissue: grey matter and white ... -
Independent Mouse Study Reinforces Remyelinating Potential of ISP Therapy
A new study demonstrates that intracellular sigma peptide (ISP) can promote remyelination in a ... -
3-D Brain Models of PPMS and Parkinson’s Off to Space Station for Research in Microgravity
The National Stem Cell Foundation announced the start of a pioneering project to investigate ... -
MS News that Caught My Eye Last Week: Gadolinium Study, Breath Test for MS Diagnosis, CBD Treatment Trial, Potential Remyelination Therapy
Study Examines Gadolinium Deposits in MS Patients’ Brains, But Still Can’t Determine Relationship with ... -
MS Possibly Linked to Greater Cancer Risk in Large, But Preliminary Norwegian Study
People with multiple sclerosis (MS) may have a greater overall risk of developing cancer ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
1st Patient Enrolled in Study of Electrical Stimulation in Treating Brain Injury
News
A first patient has been enrolled in a single-site trial to evaluate the potential of electrical stimulation, called Electroceutical Therapy, in reducing brain injury, Endonovo Therapeutics, the therapy’s developer, announced. Electroceutical Therapy is a non-invasive and wearable electronic device that uses pulsed ... Read more